WO2013057066A2 - Composition de traitement - Google Patents

Composition de traitement Download PDF

Info

Publication number
WO2013057066A2
WO2013057066A2 PCT/EP2012/070376 EP2012070376W WO2013057066A2 WO 2013057066 A2 WO2013057066 A2 WO 2013057066A2 EP 2012070376 W EP2012070376 W EP 2012070376W WO 2013057066 A2 WO2013057066 A2 WO 2013057066A2
Authority
WO
WIPO (PCT)
Prior art keywords
composition according
composition
cationic surfactant
zinc
air
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2012/070376
Other languages
English (en)
Other versions
WO2013057066A3 (fr
Inventor
Joanna Susan DAWSON
Jordan Todorov Petkov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hindustan Unilever Ltd
Unilever NV
Conopco Inc
Original Assignee
Hindustan Unilever Ltd
Unilever NV
Conopco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hindustan Unilever Ltd, Unilever NV, Conopco Inc filed Critical Hindustan Unilever Ltd
Publication of WO2013057066A2 publication Critical patent/WO2013057066A2/fr
Publication of WO2013057066A3 publication Critical patent/WO2013057066A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0295—Liquid crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners

Definitions

  • This invention relates to aerated cosmetic compositions comprising metal particulates.
  • Metal particulates are widely used in personal care compositions, for instance zinc salts which are common antidandruff agents.
  • compositions comprising such particulate materials appear gritty. Such an appearance makes the product unattractive to consumers, especially in products that are said to condition.
  • US 2004/0076651 (Wella) discloses a stable cosmetic or dermatological cream in the form of a packaged, ready-prepared foam. It can be a permanently foamed hair- treatment cream. Examples have varying amounts of cationic surfactant and other ingredients, such as alcohol. Aerated products should not to be confused with suspension of air bubbles in compositions. Such suspended air bubbles are described in WO 2008/079693 (CP Kelco) which discloses a composition comprising cationic surfactant and
  • composition described therein may further comprise suspended air bubbles. Such suspended air bubbles within a dominant majority liquid phase are not an aerated or foamed composition according to the present invention.
  • the present invention has found that aeration of the product reduces the gritty appearance. Aeration of products frequently leads to unstable products, however aerated products of the invention are stable. Summary of the Invention
  • an aerated composition comprising at least 5% by volume of air and/or inert gas at 20°C, a particulate metal compound and a lamellar phase comprising a cationic surfactant and a fatty material.
  • the invention also relates to a method of treating hair comprising the step of applying to the hair the composition described above.
  • compositions of the agents of the invention are foamed with air or inert gas up to a degree of foam-up which typically is at least 5% of air or inert gas at 20°C, preferably 10 percent and up to 100 percent, more preferably between 15 and 70 percent and particularly between 20 and 60% by volume. It is preferred that at least 25% by volume of the product is foamed.
  • compositions may be foamed with an inert gas or air, preferably they are foamed with air.
  • the aerated compositions do not comprise a hydrocarbon based propellant.
  • the definition of a stable foam is a product characterized in that it has homogeneously distributed a gaseous substance in the form of small gas bubbles which remain in this homogeneous distribution over a period of at least one week, preferably at least one month and particularly at least 6 months if stored at room temperature 20°C.
  • the average bubble size on initial manufacture is from 5 microns in diameter to 100 microns, preferably from 6 microns to 50 microns. It is preferable that the average bubble size is no more than 50 times its initial diameter, preferably no more than 40 times its original diameter after storage at 45°C for 28 days.
  • the average bubble size after 3 months storage at 45° is 500 microns or less, more preferably 300 microns or less.
  • Bubble size is based on the number average diameter.
  • the diameters are measured using an Olympus microscope, camera and
  • an aerated composition does not comprise a product that is dispersed from an aerosol, or a consumer operated container comprising a valve.
  • compositions of the invention comprise a metal particulate material.
  • Preferred metal particulates are transition metals, especially preferred are metal particulates selected from zinc and titanium. It is preferred if the metal particulate is a salt, oxide or complex, zinc salts, oxides or particulates are preferred. Particularly preferred are zinc metal particulates selected from zinc pyrithione, zinc oxide and mixtures thereof. Zinc pyrithione (ZnPTO) which is an alternate name for zinc 1 - hydroxy-2-pyridinethione is especially preferred.
  • the average particulate size of the metal salt is preferably less than 10 microns, more preferably from 0.1 microns to 5 microns.
  • the metal particulate is preferably present at a level of from 0.05 to 5 wt.%, preferably from 0.1 to 3 wt.%, more preferably from 0.25 to 2.5 wt.% based on the total weight of the composition.
  • Suitable cationic conditioning surfactants can be used singly or in admixture.
  • the cationic conditioning surfactant is a quaternary ammonium or an amine having at least one long chain alkyl group that has on average around about 16 to about 30 carbon atoms.
  • Suitable cationic surfactants for use in hair conditioners of the invention include cetyltrimethylammonium chloride, behenyltrimethylammonium chloride,
  • cetylpyridinium chloride tetramethylammonium chloride, tetraethylammonium chloride, octyltrimethylammonium chloride, dodecyltrimethylammonium chloride, , octyldimethylbenzylammonium chloride, decyldimethylbenzylammonium chloride, stearyldimethylbenzylammonium chloride, didodecyldimethylammonium chloride, dioctadecyldimethylammonium chloride, tallowtrimethylammonium chloride, cocotrimethylammonium chloride, and the corresponding hydroxides thereof.
  • cationic surfactants include those materials having the CTFA designations Quaternium-5, Quaternium-31 and Quaternium-18. Mixtures of any of the foregoing materials may also be suitable.
  • the cationic surfactant is insoluble in water. Insoluble in this context is defined as materials which at 20°C do not form isotropic, clear solutions in water at greater than 0.2 Wt%.
  • Preferred cationic surfactants are moncationic, more preferred surfactants include the compounds distearyldimethylammonium, dicetyldimethylammonium, tncetylmethylammonium r behenyltnmethylammonium, stearyl benzyl dimethylammonium, suitable amines include distearylamine,
  • the cationic salt is a combination of behenyltrimethylammonium/salt with a second cationic conditioning surfactant.
  • the cationic conditioning surfactant is behenyltrimethylammonium salt, in particular the chloride.
  • the level of cationic surfactant is preferably from 0.1 to 10%, more preferably 0.5 to 7%, most preferably 1 to 5% by weight of the total composition.
  • Fatty material Conditioners of the invention incorporate a fatty material (8 to 22 carbon atoms), preferred fatty material are fatty alcohol and fatty acid, fatty alcohol is especially preferred.
  • fatty alcohol is especially preferred.
  • the combined use of fatty alcohol materials and cationic surfactants in conditioning compositions is believed to be especially advantageous, because this leads to the formation of a lamellar phase, in which the cationic surfactant is dispersed.
  • Representative fatty alcohols comprise from 8 to 22 carbon atoms, more preferably 16 to 20.
  • suitable fatty alcohols include cetyl alcohol, stearyl alcohol and mixtures thereof. The use of these materials is also advantageous in that they contribute to the overall conditioning properties of compositions of the invention.
  • the level of fatty alcohol material in conditioners of the invention is conveniently from 0.01 to 10%, preferably from 0.1 to 5% by weight of the composition.
  • the weight ratio of cationic surfactant to fatty alcohol is suitably from 10:1 to 1 :10, preferably from 4:1 to 1 :8, optimally from 1 :1 to 1 :4.
  • compositions of the invention may comprise silicones, in particular silicone emulsions.
  • Suitable silicone emulsions include those formed from silicones such as
  • polydiorganosiloxanes in particular polydimethylsiloxanes which have the CTFA designation dimethicone, polydimethyl siloxanes having hydroxyl end groups which have the CTFA designation dimethiconol, and amino-functional
  • the emulsion droplets may typically have a Sauter mean droplet diameter (D 3,2 ) in the composition of the invention ranging from 0.01 to 20 micrometer, more preferably from 0.2 to 10 micrometer.
  • D 3,2 Sauter mean droplet diameter
  • a suitable method for measuring the Sauter mean droplet diameter (D 3 2 ) is by laser light scattering using an instrument such as a Malvern Mastersizer.
  • Suitable silicone emulsions for use in compositions of the invention are available from suppliers of silicones such as Dow Corning and GE Silicones. The use of such pre-formed silicone emulsions is preferred for ease of processing and control of silicone particle size.
  • Such pre-formed silicone emulsions will typically additionally comprise a suitable emulsifier such as an anionic or nonionic emulsifier, or mixture thereof, and may be prepared by a chemical emulsification process such as emulsion polymerisation, or by mechanical emulsification using a high shear mixer.
  • Pre-formed silicone emulsions having a Sauter mean droplet diameter (D 3 2 ) of less than 0.15 micrometers are generally termed
  • microemulsions examples include emulsions DC2-1766, DC2-1784, DC-1785, DC-1786, DC-1788 and microemulsions DC2-1865 and DC2-1870, all available from Dow Corning. These are all
  • emulsions/microemulsions of dimethiconol are also suitable.
  • amodimethicone emulsions such as DC939 (from Dow Corning) and SME253 (from GE Silicones).
  • silicone emulsions in which certain types of surface active block copolymers of a high molecular weight have been blended with the silicone emulsion droplets, as described for example in WO03/094874.
  • the silicone emulsion droplets are preferably formed from polydiorganosiloxanes such as those described above.
  • One preferred form of the surface active block copolymer is according to the following formula:
  • Silicone will generally be present in a composition of the invention at levels of from 0.05 to 10%, preferably 0.05 to 5%, more preferably from 0.5 to 2% by total weight of silicone based on the total weight of the composition. Further Ingredients
  • ingredients may include viscosity modifiers, preservatives, silicones, colouring agents, polyols such as glycerine and polypropylene glycol, chelating agents such as EDTA, antioxidants such as vitamin E acetate, fragrances, antimicrobials and sunscreens.
  • viscosity modifiers preservatives, silicones, colouring agents, polyols such as glycerine and polypropylene glycol, chelating agents such as EDTA, antioxidants such as vitamin E acetate, fragrances, antimicrobials and sunscreens.
  • compositions of this invention also contain adjuvants suitable for hair care.
  • adjuvants suitable for hair care Generally such ingredients are included individually at a level of up to 2%, preferably up to 1 %, by weight of the total composition.
  • suitable hair care adjuvants are: (i) natural hair root nutrients, such as amino acids and sugars.
  • suitable amino acids include arginine, cysteine, glutamine, glutamic acid, isoleucine, leucine, methionine, serine and valine, and/or precursors and derivatives thereof.
  • the amino acids may be added singly, in mixtures, or in the form of peptides, e.g. di- and tripeptides.
  • the amino acids may also be added in the form of a protein hydrolysate, such as a keratin or collagen hydrolysate.
  • Suitable sugars are glucose, dextrose and fructose. These may be added singly or in the form of, e.g. fruit extracts.
  • Ceramides are available by extraction from natural sources, or as synthetic ceramides and pseudoceramides.
  • a preferred ceramide is Ceramide II, ex Quest.
  • Mixtures of ceramides may also be suitable, such as Ceramides LS, ex Laboratories Serobiiques. - free fatty acids, for cuticle repair and damage prevention.
  • Examples are branched chain fatty acids such as 18-methyleicosanoic acid and other homologues of this series, straight chain fatty acids such as stearic, myristic and palmitic acids, and unsaturated fatty acids such as oleic acid, linoleic acid, linolenic acid and arachidonic acid.
  • a preferred fatty acid is oleic acid.
  • the fatty acids may be added singly, as mixtures, or in the form of blends derived from extracts of, e.g. lanolin.
  • the structure of the composition comprises a lamellar structure. It is preferred if the composition does not have a micellar structure.
  • the composition is an aerated product in that it is packaged in an aerated form.
  • compositions of the invention are primarily intended for topical application to the body, preferably the hair and/or scalp of a human subject in rinse-off or leave- on compositions.
  • compositions provided by the invention may be aqueous conditioner compositions, used by massaging them into the hair followed by rinsing with clean water prior to drying the hair.
  • the invention will be further described by way of the following non-limiting examples. Examples A hair conditioner composition was made as specified in Table 1 using the following preparative method.
  • Nipagin M, Gemamin BTLF and Lanette S3 were added gradually to hot water in a mixer with stirring. The mixer was sealed and evacuated until bubbles began to rise. The product was homogenised for 15 minutes, the product was cooled and quench water was added followed by silicone. After further cooling perfume was added. The product was further evacuated and homogenised at 40% for 5 min. ZnPTO or ZnO was then added the base followed by water. Comparative Examples were prepared as above, but the metal particulate (when present) was added without aeration.
  • Foam stability was measured using turbiscan measurements.
  • the essence of the turbiscan measurements is that it measures the backscattered light at 135 degrees.
  • the wavelength of the laser used is 880 nm which is Near Infra Red (NIR) region.
  • NIR Near Infra Red
  • the intensity of the scattered light depends on the size of the bubbles. The smaller the size the larger the intensity and vice versa. Stable foams have smaller bubbles and hence larger intensity measurements.
  • the samples were aerated and vials were filled with the aerated conditioner and kept in a storage ovens at 25°C.
  • Foam stability was measured using turbiscan measurements at regular intervals without any intervention. The method is not intrusive and the microstructure (bubble size is not affected by the measurement itself) evolution can be followed in time.
  • Figure 1 demonstrates an aerated product and non-aerated product according to Examples 1 and A. It can be seen that the zinc particulates are obvious in Example A, but can not be seen in Example 1 .

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)

Abstract

L'invention porte sur une composition aérée comprenant au moins 5 % en volume d'air et/ou de gaz inerte à 20°C, un composé métallique particulaire et une phase lamellaire comprenant un tensioactif cationique et une matière grasse.
PCT/EP2012/070376 2011-10-17 2012-10-15 Composition de traitement Ceased WO2013057066A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11185365 2011-10-17
EP11185365.1 2011-10-17

Publications (2)

Publication Number Publication Date
WO2013057066A2 true WO2013057066A2 (fr) 2013-04-25
WO2013057066A3 WO2013057066A3 (fr) 2013-11-14

Family

ID=47010623

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2012/070376 Ceased WO2013057066A2 (fr) 2011-10-17 2012-10-15 Composition de traitement

Country Status (2)

Country Link
AR (1) AR088349A1 (fr)
WO (1) WO2013057066A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018053213A1 (fr) * 2016-09-19 2018-03-22 The Procter & Gamble Company Composition de mousse, produits aérosols et leurs procédé d'utilisation pour améliorer les avantages sensoriels sur la peau
WO2018057413A1 (fr) * 2016-09-23 2018-03-29 The Procter & Gamble Company Compositions de mousse stables et leurs procédés d'utilisation pour fournir des bénéfices sensoriels et visuels améliorés à la peau

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003094874A1 (fr) 2002-05-10 2003-11-20 Unilever Plc Composition pour shampooing conditionneur
US20040076651A1 (en) 2000-11-24 2004-04-22 Werner Brocks Cosmetic or dermatological agent in the form of a creamy permanent mousse or a stable foamed cream
WO2008079693A1 (fr) 2006-12-19 2008-07-03 Cp Kelco U.S. Inc. Systèmes tensioactifs cationiques comprenant de la cellulose microfibreuse

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2366797A (en) * 2000-09-13 2002-03-20 Procter & Gamble Process for making foam component by pressurising/depressurising
US6586483B2 (en) * 2001-01-08 2003-07-01 3M Innovative Properties Company Foam including surface-modified nanoparticles
ZA200507017B (en) * 2004-02-04 2007-03-28 Foamix Ltd Cosmetic and pharmaceutical foam with solid matter
US20110193032A1 (en) * 2010-02-05 2011-08-11 Tecona Technologies, Inc. Composition for making transparent conductive coating based on nanoparticle dispersion

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040076651A1 (en) 2000-11-24 2004-04-22 Werner Brocks Cosmetic or dermatological agent in the form of a creamy permanent mousse or a stable foamed cream
WO2003094874A1 (fr) 2002-05-10 2003-11-20 Unilever Plc Composition pour shampooing conditionneur
WO2008079693A1 (fr) 2006-12-19 2008-07-03 Cp Kelco U.S. Inc. Systèmes tensioactifs cationiques comprenant de la cellulose microfibreuse

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018053213A1 (fr) * 2016-09-19 2018-03-22 The Procter & Gamble Company Composition de mousse, produits aérosols et leurs procédé d'utilisation pour améliorer les avantages sensoriels sur la peau
WO2018057413A1 (fr) * 2016-09-23 2018-03-29 The Procter & Gamble Company Compositions de mousse stables et leurs procédés d'utilisation pour fournir des bénéfices sensoriels et visuels améliorés à la peau
US10463584B2 (en) 2016-09-23 2019-11-05 The Procter & Gamble Company Stable foam compositions and methods of using the same to provide enhanced sensory and visual benefits to skin

Also Published As

Publication number Publication date
WO2013057066A3 (fr) 2013-11-14
AR088349A1 (es) 2014-05-28

Similar Documents

Publication Publication Date Title
JP6268094B2 (ja) 組成物
EP1067899B1 (fr) Compositions capillaires
CN113557006B (zh) 用于毛发的沉积系统
EP2293768A1 (fr) Composition
TWI526226B (zh) 組合物
JP7809439B2 (ja) 改良されたすすぎ特性を有する毛髪組成物
WO2013064598A2 (fr) Composition de soin capillaire
WO2012059440A2 (fr) Composition de traitement
JP7809440B2 (ja) 改善されたリンスのためのヘアコンディショニング組成物
CN113226263B (zh) 用于毛发的沉积体系
RU2810339C2 (ru) Система осаждения для волос
EP3723715B1 (fr) Compositions de soins personnels et procédés pour améliorer le maintien des boucles des cheveux
TW201321026A (zh) 處理組成物
BR112014017892B1 (pt) Composição para o tratamento do cabelo
EA044138B1 (ru) Система осаждения для волос
BR112021009892B1 (pt) Composição de tratamento capilar, método não terapêutico de tratamento capilar e uso de um diéster quaternário
EA040884B1 (ru) Композиция для волос, имеющая улучшенные характеристики смываемости

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12770510

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct app. not ent. europ. phase

Ref document number: 12770510

Country of ref document: EP

Kind code of ref document: A2